| ALK

Careers

Careers at ALK

Join us on our purposeful mission to help people living with allergy worldwide.

ALK is a global specialty pharmaceutical company focused on allergy. For more than a century, we’ve been at the forefront of long-term allergy treatment, with a strong focus on innovation. We’ve entered our second century as a global pioneer in the field of allergy with an ambition to continue our growth and a mission to help five million people living with allergies by 2030.

With our roots and headquarter in Denmark, ALK employs around 2,800 people worldwide and we’re always on the lookout for new colleagues to join us within different parts of our organisation and with different backgrounds.

We invite you to explore our current career opportunities and join a team that values collaboration, innovation, and a shared commitment to helping people affected by allergies worldwide.

Explore current

opportunities at

ALK for a career

guided by a

strong purpose.

This is ALK

Allergy impacts and challenges the lives of millions of adults and children every day. At ALK, our purpose is to improve the lives of people living with allergies. Building on our strong heritage, we are guided by our strategy, Allergy+, that shows us a clear path towards this goal through focus, innovation, cultivation and optimisation. 

More than a century of scientific expertise

Our comprehensive knowledge of the biological mechanisms behind allergy has laid the groundwork for creating a variety of allergy immunotherapy treatments and management solutions, which are central to our current product lineup.

We are dedicated to furthering scientific advancements and consistently introducing new concepts in allergy research and treatment. Our scientific efforts primarily focus on respiratory allergy, food allergy, anaphylaxis, and adjacent disease areas.

Learn more about our scientific expertise and focus areas here.

Working with nature – from farm to pharma

The main ingredients in our allergy immunotherapy products at ALK, are natural allergens, such as grass pollen and house dust mites. Each year, we grow, collect and harvest tons of these raw materials at our production facilities. Handling natural allergens requires thorough analysis, standardisation and quality control processes to ensure that biological variations do not impact the product quality. Watch the video to learn more about how we harness nature for our allergy immunotherapy products – We call it “from farm to pharma”.

Helping people across the globe

With production sites in the USA, Spain, France and Denmark, and with offices in more than 20 countries worldwide, our global workforce prioritise collaboration across borders and functions to reach people with allergy in 46 markets.

Find our current opportunities at your preferred location here.

Learn more about our global presence and our company here.

A culture of collaboration and inclusion

As a global company, we’re committed to fostering a working environment characterised by cross-cultural collaboration and inclusion where every employee can thrive and develop in their career journey. We find it essential for our continued ability to innovate and help people across the globe.

To cultivate our inclusive environment, we focus on training our leaders in cultural awareness and inclusive leadership, promoting an unbiased mindset in recruitment processes, and launching awareness campaigns that highlight inclusion as a vital driver of engagement.  

Our company size allows for meaningful involvement of employees across the organisation and means that each individual’s contributions make a significant impact on our success as we grow as an organisation.

Guided by our three Cultural Beliefs — Do the Right Thing, Pursue Growth, and Build Bridges — we empower each other to perform our best every day as we strive to develop innovative allergy treatments for people with allergy worldwide. We encourage open dialogue and involvement and we work to ensure that everyone feels valued.

And we’re committed to doing it all in a sustainable manner. You can learn more about our efforts and ambitions within environmental, social and governance sustainability practices a here.

Our business functions

Previous
  • Avatar

    Research and Development

    At the core of ALK, innovation thrives. Our R&D function develops world class therapies for allergy management in a collaborative environment. Fostering new insights into research, this function is shaping the future of allergy treatment.

  • Avatar

    Product Supply

    ALK's Product Supply team helps ensure smooth global delivery of allergy treatments from our manufacturing sites spread across Europe and the USA. Their focus is on meeting market needs and demands, while collaborating as a dynamic and international Product Supply team.

  • Avatar

    Global Quality

    In our Global Quality team, colleagues worldwide are ensuring the highest standards in product safety and efficiency, driving continuous improvements and compliance across the organisation.

  • Avatar

    Commercial Operations

    ALK's passionate Commercial Operations team drive our international sales growth with a strong focus on our purpose to help adults and children with allergy. If you thrive in a professional sales focused environment this team is for you.

  • Avatar

    People & Organisation

    People & Organisation is a global team, driving a thriving workplace culture across borders and functions, supporting employee development, and enhancing engagement for all ALK colleagues. This function covers the areas of Human Resources, Corporate Communications, and Sustainability.

  • Avatar

    Global Business Support

    At ALK, our Global Business Support function covers the areas IT, Corporate Affairs & Legal, Finance, Procurement, and Investor Relations. Across the function, colleagues collaborate to ensure the necessary foundation for our global teams to succeed in shaping the future of allergy treatments.

  • Avatar

    Global Strategy & Corporate Development

    The Global Strategy & Corporate Development team shape ALK's future direction, drive strategic initiatives, and foster impactful partnerships and collaborations that enhance our growth and enable us to help more people with allergy.

Next

Meet your future colleagues

We strive to bring together a diverse group of individuals and to ensure that every employee feels valued, respected, and safe to be their authentic selves at work.

Below, you can get to know some of our talented employees, helping to ensure that ALK stays in the forefront of allergy research and solutions. Explore the presentations below to discover their stories, insights, and career paths, all reflecting our vibrant workplace culture and collaborative spirit.

Previous
  • Avatar

    Magnus

    Magnus Lindqvist joined ALK Sweden in 2003 after earning his Master's in Zoophysiology. He progressed from sales representative to Medical Science Liaison, where he blends scientific expertise with sales experience: “A career at ALK offers many opportunities for development. If you bring the drive, ALK will support your journey.”


  • Nicoline

    Nicoline Mi Jung Kirk joined ALK in 2021 as Global Marketing Program Leader, drawn by our strong purpose. Today, she’s the Associate Director of Global Marketing Projects. She thrives in ALK's collaborative culture and has already led several strategic projects across functions and regions, significantly contributing to our mission to help 5 million people with allergies by 2030.

  • Avatar

    Andrew

    Before joining ALK Oklahoma in 2022, Andrew O'Keefe spent years in the oil industry. He sought a purpose-driven role that offered a better work-life balance. At ALK, he found both – contributing to allergy care while embracing a collaborative culture. Andrew aims to advance automation and innovative technologies in our production processes


  • Lika

    Lika Thiesen joined ALK in 2024 as Executive Vice President of Global People and Organisation, leading a team that has a significant impact on our workplace: “I believe it’s essential to create an environment where all employees feel included and empowered. I’m passionate about supporting professional development and establishing clear paths for growth within the organisation.”

  • Avatar

    Neera

    Neera Chakrapani joined ALK in  2023 as a postdoctoral researcher in Global Research and Drug Discovery. Today Neera develops diagnostic methods. In her role, Neera also collaborate with universities, and her research is already impacting allergy treatment. She values ALK’s culture, teamwork and open dialogue, and is excited to make a meaningful impact in allergy research.

  • Avatar

    Isabel

    Isabel Courinha Martinho joined ALK Spain in 1985 after graduating as a nurse. She wanted to work with people and help improve their health, and joined ALK as a research assistant. Since then, she has evolved into holding key roles in medical marketing and regulatory affairs: “ALK provides a supportive environment for continuous learning. The opportunities I've been given to explore and grow have been immensely rewarding.”


  • Ihor Mycak

    With a natural passion for innovation and optimisation, Ihor Mycak has grown his career from his original field of expertise within finance to a leading role in commercial excellence since joining ALK in 2014. As Head of Global Commercial Excellence, Ihor drives impactful projects like integrating global commercial data platforms and accelerating smarter, faster decision-making. Ihor’s work and drive for pace play a key role in advancing ALK’s efforts towards our ambitious mission of helping 5 million people with allergy annually by 2030.

  • Avatar

    Tomasz

    Tomasz Ryś joined ALK Poland in 2018. In Global Finance's Product Supply team, he aims to find optimisation opportunities by helping product supply and finance speak the same language. Since his entry to the company, Tomasz has taken on increasing responsibilities, leading significant standardisation projects and implementing vital performance reports: “If you want to grow within a supportive, innovative company, ALK is the place to be."


  • Cecilia

    Cecilia Rossetti has a passion for science and for making a difference in healthcare. With a master’s degree in analytical chemistry from her home country, Italy, and a PhD in pharmaceutical chemistry from Norway, she has a strong expertise in proteomics and mass spectrometry. Cecilia joined ALK in 2022, and today, as a Senior Lead Scientist, she leads innovative allergy research projects at ALK, ranging from phase 2 studies to early discovery initiatives with the potential to find innovative ways to address allergy in the future.

Next
 

Meet our leaders

Dive into the videos below to learn more about the people behind the titles in our Executive Leadership Team at ALK.

Peter Halling

Claus Steensen Sølje

Christian G. Houghton

Lika Thiesen


 

Jacob Glenting

Jan Engel Jensen

xxxxxxx

xxxxxxx

If ALK sounds like a place for you, we hope you will check out our current opportunities here.

Last updated: 01.04.2026

Symposium on Specific Allergy SOSA

Healthcare professionals

Symposium on 
Specific Allergy SOSA

Symposium on Specific Allergy

Symposium on Specific Allergy (SOSA) is a global forum dedicated to advancing knowledge about specific allergies.

Since 1994, SOSA has been conducted in physical, virtual, and hybrid formats, engaging over 25,000 healthcare professionals worldwide.

SOSA focuses on delivering comprehensive content that closely aligns with the latest developments in allergy research. SOSA has been fortunate to feature esteemed presenters who are leading experts in their respective fields, representing a global network to ensure thorough and impactful knowledge sharing.

The symposia have varied in length, ranging from half a day to two days depending on the format. By attending the symposium, participants have had the opportunity to earn CME credits.

You can find an overview of previous SOSAs, along with examples of previously presented programmes here.

Main objectives of SOSA

Foster ongoing dissemination of scientific knowledge to enhance outcomes for patients with allergy

Provide key updates on recent advancements in allergic diseases and encourage scientific discussions

Facilitate the optimisation of clinical practice aimed at improving outcomes for allergic patients


Expand scientific knowledge
Enhance the understanding of allergies and the treatments through scientific insights

Increase treatment awareness
Equip healthcare providers with the tools to effectively communicate all available treatment options to patients, facilitating informed decision-making

Continuous engagement
Establish opportunities for meaningful interactions and sustained engagement among healthcare professionals globally

Global expertise to local impact
Facilitate broader access to events and educational activities to enrich knowledge and peer-to-peer medical collaboration

Previous SOSAs

SOSA is a unique global medical forum for specific allergies and has been held as in-person, hybrid, and virtual formats since 1994, with support from ALK. Previous SOSA-sessions will be made available on ALK Pro Global

SOSA 2021
SOSA 2015
SOSA 2023 Copenhagen
SOSA 2023 Copenhagen
SOSA 2023 Copenhagen
Last updated: 25.09.2025

Privacy notice - shareholders, proxies and advisors

Privacy notice for shareholders, proxies and advisors

March 2025

The purpose of this privacy notice is to describe how ALK-Abelló A/S (ALK), as part of its handling of investor relations, collects, processes and stores personal data about its shareholders, proxies, and advisors, including registration in the register of shareholders and the convening and holding of Annual General Meetings. In addition, this privacy notice aims to provide information about your rights under the General Data Protection Regulation (GDPR). Your privacy is important to ALK.

1. Identity and contact details of the data controller

The legal entity responsible for processing your personal data is:

 

ALK-Abelló A/S

Address: Bøge Allé 1

2970 Hørsholm

Denmark

Tel.: +45 45747576

Email: data.protection@alk.net

 

Our Data Protection Officer:

Bech-Bruun Advokatpartnerselskab

CVR nr.: 38538071

Gdanskgade 18

2150 Nordhavn

Denmark

Tel.: +45 72 27 30 02

Email: dpo.alk@bechbruun.com

Encrypted email via: https://dpo.bechbruun.com/alk

 

If you have any questions regarding the processing of your personal data, you can always reach out to ALK or our Data Protection Officer.

2. Detailed information on the processing carried out by ALK

We process your personal data to comply with the legal obligations set out in corporate laws, as well as announcements to the Danish Financial Supervisory Authority and Nasdaq Copenhagen.

In connection with ALK’s Annual General Meeting, ALK collects, stores, and processes the personal data. This occurs in different respects, as follows:

Purpose: Identification of shareholders and maintenance of the register of shareholders, including the shareholder portal.

ALK will collect and process information about each shareholder, including:

  • Name, email address, home address
  • Portfolio of shares, voting rights, date of acquisition/sales
  • Username and password, account number with VP securities, investor ID and custodian bank

 

Lawfulness of Processing: ALK processes personal data in accordance with:

  • Article 6(1)(c) of GDPR to comply with obligations and shareholder’s rights set out in section 50 of the Danish Companies Act
  • Article 6(1)(f) of GDPR for shareholders identification to be able to answer their request and to communicate with them (legitimate interest)

 

Storage period:

ALK will retain your personal data for up to 5 years plus the current financial year after you no longer own shares in ALK.


 

Purpose: Convening and the holding of the Annual General Meetings.

ALK will process personal data to invite shareholders to the Annual General Meetings and enable them to exercise their rights at the meetings, issue proxies, and vote by post.

ALK processes personal data from shareholders' advisors so that the advisor can attend the Annual General Meeting. In addition, ALK processes this information to issue admission cards to shareholders, proxies, and advisors.

ALK will collect and process information about each shareholder, including:

  • Name, email address, home address
  • Attendance at the Annual General Meeting, advisor’s attendance at the meeting
  • Proxies, votes cast, including vote by post and portfolio of shares

 

Lawfulness of Processing: ALK processes personal data in accordance with:

  • Article 6(1)(c) of GDPR to comply with legal obligations in section 93 of the Danish Companies Act

 

Storge period:

ALK will keep your personal data for up to 5 years plus the current financial year after you no longer own shares in ALK.

The notice, including the agenda with complete proposals and certain auxiliary documents (such as, but not limited to, proxy forms and correspondence voting forms), is published as a company announcement through Nasdaq Copenhagen and on ALK’s website. It is also distributed by email to shareholders who have requested it and will remain publicly available on our website for fifteen years.

Additionally, ALK may retain the notice, agenda, and auxiliary documents for as long as necessary to protect and pursue the interests of ALK and its shareholders. Materials documenting the company’s history, decisions made, etc., are retained for as long as ALK exists.


 

Purpose: Screening of individuals subject to EU, UK, or US sanctions.

ALK is legally obligated to ensure that individuals subject to economic sanctions imposed by the European Union, the United Kingdom, or the United States of America do not exercise shareholder rights during the Annual General Meeting. To fulfil this obligation, ALK may process personal data of shareholders participating in the Annual General Meeting by screening their information against relevant sanctions lists.

ALK will process the following personal data of shareholders based on information registered in the shareholder register:

  • Name and home address

 

Lawfulness of Processing: ALK processes personal data in accordance with:

  • Article 6(1)(c) of GDPR to comply with applicable sanctions laws and regulations, which include preventing sanctioned individuals from exercising shareholder rights.
  • Article 6(1)(f) of GDPR as ALK has a legitimate interest in ensuring compliance with international sanctions regimes, maintaining corporate integrity, and mitigating legal and financial risks.

 

Storage period:

Personal data collected and processed for sanctions screening will be retained only for as long as necessary to fulfil the legal obligations and purposes stated above.


 

Purpose: Confirmation of standing for election.

Persons standing for election at the Annual General Meeting must confirm their eligibility, along with information about other managerial responsibilities.

In this context, and for the purpose of verifying the candidate’s identity and eligibility, ALK will collect and process personal data, including the candidate’s name and managerial positions held.

 

Lawfulness of Processing: ALK processes personal data in accordance with:

  • Article 6(1)(c) of GDPR to comply with Danish corporate law as set out in section 112 of the Danish Companies Act
  • Article 6(1)(f) of GDPR for processing personal data to ensure transparency in corporate governance, facilitate the election process, and enable subsequent regulatory registrations (legitimate interest)

 

Storage period:

Personal data collected and processed will be retained for as long as necessary to protect and pursue the interests of ALK and its shareholders.


 

Purpose: Submitting questions and proposals prior to the Annual General Meeting, handling of questions and exercising the right to speak at the Annual General Meeting as well as preparation of the minutes of the Annual General Meeting.

If questions are answered in writing prior to the Annual General Meeting, ALK will process your information in order to present the questions, answers, and the name of the person who submitted the question at the Annual General Meeting.

If a proposal regarding a specific issue is included on the agenda for the Annual General Meeting, ALK will process the name of the person and the proposal.

If you exercise your right to speak, your personal information will be recorded in the minutes.

Lawfulness of Processing: ALK processes personal data in accordance with

  • Article 6(1)(c) of GDPR to comply with legal obligations on section 78, 90, and 101 of the Danish Companies Act
  • Article 6(1)(f) of GDPR (legitimate interest) to be able to identify shareholders and proxies in order for them to present proposals and questions prior to and during the Annual General Meeting and to exercise their right to speak

Storage period

  • ALK will store minutes of the Annual General Meeting until it is no longer necessary for ALK to protect ALK and shareholder’s interest, including for the purpose of documenting the deliberations and resolutions passed at Annual General Meeting.

 

Purpose: Audio and/or visual recording.

General Annual Meetings are audio and/or visually recorded, and ALK may webcast the Annual General Meeting and maintain a recording on ALK’s webpage.

ALK will process your personal data, such as your voice and image, if you exercise your right to speak during the Annual General Meeting.

The recording will include the agenda (including proposals from shareholders) and may also capture questions or statements submitted in writing during the meeting.

Lawfulness of processing: ALK processes your personal data in accordance with

  • Article 6(1)(f) of GDPR (legitimate interest) in processing the recordings to use them to prepare the minutes and in documenting the proceedings at the Annual General Meeting and making it available to shareholders and media who are unable to attend or view the live webcast of the Annual General Meeting.

Storge period

  • ALK will keep a recording publicly available on demand on its website for a period of up to 5 years after the Annual General Meeting

3. Recipients of the personal data

i       ALK EMPLOYEES & EXTERNAL PROCESSORS

The recipients of your personal data will be employees of entities belonging to the ALK Group and external processors providing specific services while processing personal data on our behalf. They will receive your personal data only on a ‘need-to-know’ basis, subject to confidentiality obligations and after signing legal agreements. Furthermore, we may share your data with the general public through publication on ALK’s website in accordance with applicable law.

 

 

ii       INDEPENDENT THIRD PARTIES

When needed, we may disclose your personal data to third parties, such as Nasdaq Copenhagen A/S and Public Authorities, such as the Danish Business Authority, attorneys, or third-party auditors.

 

 

iii       TRANSFERS OF DATA FROM EU/EEA TO THIRD COUNTRIES

If we share data from the EU/EEA with a company or ALK affiliate in a third country, we will apply contractual clauses that meet EU standards to ensure the receiving company handles personal data appropriately, unless the country where the company operates is already deemed by the EU to offer an adequate level of data protection. More information about such clauses is available here. If data transfers are required in other situations, we will inform you about the specific compliance measures in place to enforce EU law.

4. Data Subject Rights

a) Right to access

     You have the right to request access to your personal data held by ALK, as well as additional details.

 

b) Right to rectification

      You have the right to request correction of inaccurate or incomplete personal data.

 

c) Right to erasure

     You have the right to request the deletion of your personal data, except when retention is required by       law.

 

d) Right to restrict processing

      You have the right to object to restriction of your personal data.

 

e) Right to object

      You have the right to object to the processing of your personal data.

 

f) Right to data portability

      In specific situations, you are entitled to receive your personal data in a structured, widely used, and        machine-readable format.

 

If you would like to exercise any of these rights, please contact us using the contact details provided in section 1.

5. Right to Complain

You have the right to file a complaint with the Data Protection Authority if you are dissatisfied with the way we process your personal data. Contact information of the Data Protection Authority can be found on their website.

If you have any questions or concerns about this privacy notice or our processing of your personal data, please contact us using the contact details provided in section 1.

Last updated: 10.03.2025

Testing components

Previous
  • Avatar

    Research and Development

    At the core of ALK, innovation thrives. Our R&D function develops world class therapies for allergy management in a collaborative environment. Fostering new insights into research, this function is shaping the future of allergy treatment.

  • Avatar

    Product Supply

    ALK's Product Supply team helps ensure smooth global delivery of allergy treatments, meeting market needs and demands, while collaborating as a dynamic and international Product Supply team

  • Avatar

    Global Quality

    In our Global Quality team, colleagues worldwide are ensuring the highest standards in product safety and efficiency, driving continuous improvements and compliance cross the organisation.

  • Avatar

    Commercial Operations

    ALK's passionate Commercial Operations team drive our international sales growth with a strong focus on our purpose to help adults and children with allergy. If you hrive in a professional sales focused environment this team is for you.

  • Avatar

    People & Organisation

    People & Organisation is a global team, driving a thriving workplace culture across borders and functions, supporting employee development, and enhancing engagement for all ALK colleagues

Next
Graph-left Graph-right
Graph-left Graph-right
Graph-left Graph-right

Henning Løwenstein contributed significantly to the identification, categorisation, isolation, characterisation, and nomenclature of allergens and allergen components, recombinant allergens, standardization of allergen extracts for diagnosis and treatment of allergic diseases as well as translation of research understandings into robust clinical trials.

To recognise this outstanding contribution, ALK established and dedicated The Henning Løwenstein Research Award to the researcher Henning Løwenstein on his 25th anniversary of working at the company.

Join this year's award ceremony live on 13 November at 15.00 p.m. CET right here! Use the password: ALKSOSA2025 to enter the livestreaming.


Expand scientific knowledge
Enhance the understanding of allergies and the treatments through scientific insights

Increase treatment awareness
Equip healthcare providers with the tools to effectively communicate all available treatment options to patients, facilitating informed decision-making

Continuous engagement
Establish opportunities for meaningful interactions and sustained engagement among Health Care Professionals globally, before and after the event through education

Global expertise to local impact
Facilitate broader access to events and educational activities to enrich knowledge and peer-to-peer medical collaboration
30 years of advancing allergy immunotherapy
Last updated: 03.11.2025

Governance

Corporate culture

Promoting a culture of transparency and accountability, ALK encourages employees, suppliers, vendors, consultants or others with a work-related relationship with ALK to raise serious and sensitive concerns using our whistleblower hotline, ALK Alertline.

We provide annual Code of Conduct training for all employees. In 2025, 99% (2024: 98%) of employees across all functions completed the training.

ALK Alertline
ALK's whistleblower hotline enables employees, business partners and other stakeholders to report any serious and sensitive concern in a confidential and anonymous manner.
Code of Conduct
ALK's Code of Conduct outlines the standards of behaviour that we expect from all ALK employees when interacting with stakeholders.

Animal welfare

When developing new treatments, we conduct tests on animals to ensure that patients receive safe and effective medicines. We only use animals for research purposes when no scientifically valid alternative exists.

In 2025, we introduced an animal welfare policy, formalising ou commitment to the highest standards of animal welfare within research and development activities.

We are committed to the 3R principles (Replace, Reduce, and Refine). All research complies with relevant national and international regulations, including the EU Directive on protection of animals used for scientific purposes, and Federation of European Laboratory Animal Science Associations (FELASA) guidelines, with equivalent standards upheld globally.

Code of Conduct
Anti-corruption Policy
Data Ethics Policy
Third party code of conduct
Tax policy
Whistleblower Policy
UK Modern Slavery Act statement 2025

Partnering for sustainability

The challenges of climate change require commitments and partnerships

Last updated: 20.02.2026

Social

Own workforce

Employee engagement

ALK is focused on fostering the wellbeing, professional growth and inclusivity of its employees. This helps ALK to attract and retain the key competences needed for its operations worldwide. By prioritising the development and engagement of employees, ALK ensures that staff are empowered, motivated and equipped to contribute to the organisation’s mission to improve the lives of people with allergy all over the world.

Our commitment to fostering a culture of open communication and collaboration is exemplified through our annual global engagement survey results. This year's participation rate remained high at 94% (2024: 95%). The overall engagement score increased to 8.6 (2024: 8.3), positioning ALK in the top 5% against the international healthcare benchmark for the second year in a row.

Competence development

Recognising the pivotal role of development in enhancing employee retention and performance, ALK seeks to foster a culture of continuous learning and growth for its workforce. Development agreements are integrated as a fundamental component of our annual people processes for all employees to gain a clear direction for their learning and growth opportunities as part of the Global People Performance Process.

Inclusive culture

At ALK, fostering an inclusive culture is essential for effectively addressing the diverse needs of patients and partners.

ALK has set a target to have at least 40% of the underrepresented gender in the ELT and their direct reports in managerial positions, by 2028.

We track employees’ perceptions of D&I and their sense of psychological safety via the annual employee engagement survey. In 2025, the overall perception of diversity in ALK rose to 8.4 (2024: 8.2) and stands 0.3 points above the industry benchmark.

Health and safety

Health and safety management is an essential part of ALK’s operations, especially in production and farming activities where employees may face workplace risks. We record and monitor workplace injuries across all sites, and all employees are encouraged to report unsafe conditions.

In 2025, work-related accident rate remained low and decreased to 4 accidents with absence across all sites.

Regular safety dialogues with workers councils or employees
This collaborative approach ensures that the perspectives of our employees are considered in the development and improvement of safety policies and procedures.
Monthly safety inspections across all production facilities
Identifies and addresses potential hazards, and encourages employees to report near misses, allowing us to implement corrective measure and improve safety protocols where needed.
Digitalisation of near miss frequency reporting
Near misses are invaluable opportunities to identify potential hazards and prevent accidents before they occur.

Value chain workers

ALK’s Third-Party Code of Conduct outlines the standards of behaviour that we expect from all third parties globally when it comes to business conduct and treatment of employees. The Third-party Code of Conduct is an integral part of ALK's GxP (good practice) supplier agreements. Any breaches of the standards in the ALK Third-Party Code of Conduct can be reported through Alertline whistleblower platform.

Through an external evaluation platform, ALK assesses environmental, labour, and human rights risks. During 2025, ALK assessed over 1,400 of its suppliers, covering 97% of the procurement spend. None were identified as very high risk from an ESG perspective.

Consumers and end users

2 2022 and 2023 figures are not covered by the Independent Auditor’s limited assurance report on the Sustainability Statement

ALK aims to help 5 million people with allergy annually by 2030 to advance its positive impact.

In 2025, an estimated 3.1 million people, an increase of 500,000, were treated with ALK’s products.

Product safety and quality

We continuously monitor the safety and quality of our products through a robust, global pharmacovigilance system designed to identify, assess, and address side-effects and safety concerns, covering both clinical trials and marketed products. This ensures that the safety profile of our products is optimized for the benefit of users, and that the relevant authorities can be made aware of any safety issue arising from our products to facilitate immediate action.

Reducing barriers to access

To reduce barriers to access, we engage systematically in educational activities with healthcare professionals through training sessions, targeted newsletters, large multi‑market webinars. We continuously enhance our healthcare professional portals offering practical tools and educational resources.

Policy downloads

Code of conduct
Diversity and Inclusion Policy
UK Modern Slavery Act statement 2025
Access to Medicine
Third Party Code of Conduct

Partnering for sustainability

The challenges of social action require commitments and partnerships.

Last updated: 20.02.2026

Environment

Climate change

Climate change poses a direct threat to respiratory health by increasing the potential for allergen exposure. For example, climate change can extend pollen seasons and/or alter the distribution and abundance of allergenic plants. As a company focused on improving the lives of individuals with allergies, we recognise our responsibility to contribute to a healthier planet. Thus, we are committed to mitigating climate change in a manner that safeguards both the environment and people with allergies.

Setting science-based targets

Our carbon emission reduction targets have been confirmed by SBTi (Science Based Targets initiative) to be in line with what the latest climate science deems necessary to meet the goals of the Paris Agreement - limiting global warming to 1.5°C above per-industrial levels. The setting of these targets underscores our commitment to mitigate the tangible impacts and risks associated with climate change.

Read more in our press release


Transition plan

In order to reach our goal of 42% carbon emission reduction by 2030, we have developed a transition plan outlining our decarbonisation levers through 2030:

Decarbonising production boilers
powered by natural gas or gas oil, replacing them with heat pumps and other low‑carbon solutions.
Electrifying our company fleet,
prioritising regions with well-developed charging infrastructure.
Substituting refrigerant chemicals
in coolers, prioritizing refrigerants with lower global warming potential.
Transitioning towards renewable energy,
purchasing certified energy certificates where direct sourcing of renewable energy is not yet possible.

Progress on transition plan

Driven by our decarbonisation actions, we have decreased carbon emissions from our own operations by 11% compared to our 2022 science-based target baseline. Our scope 1 and 2 emissions now account for  4,883 tCO2e (2022: 5,492 tCO2e), on track with our 42% target by 2030. The main drivers of the reduction are the electrification of the boiler in France as well as the transition to electrical company fleet. 

In 2025, through an expanded supplier screening and engagement on carbon‑reduction targets, we increased the share of suppliers with science‑based targets to 50% (2024: 35%).

Pollution

All chemicals used by ALK are regulated under the Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) Regulation. Some chemicals are classified as Substances of Concern (SoCs) or Substances of Very High Concern (SVHCs) due to their potential environmental and human health impacts.

ALK ensures compliance with REACH and local regulations for responsible use and handling of chemicals in production. Relevant actions and resources are continuously evaluated and allocated at the operational level to maintain high environmental and safety standards.

Water

Our production facilities rely on the consumption of water, which is an important natural resource in many areas. Our Madrid site, located in a water‑scarce region, represents only 7% of total consumption.

We monitor our water use in our production facilities to ensure compliance with local legal regulation. In 2025, ALK’s production facilities consumed 181,000 m3 water in 2025.

Irrigation of allergenic source materials on ALK owned and leased farmland is our principal source of water use, accounting for 55% of total use in 2025. We practice crop rotations at our farmland, to maintain soil health, manage nutrient balances, and support long-term yield stability. As a results, the water used for irrigation can fluctuate year on year, depending on the number of irrigated fields.

 

Biodiversity and Ecosystems

The majority of ALK’s allergenic source materials - pollens, mites, moulds and insect venom - are sourced from nature on ALK’s own and leased land in North America. ALK is committed to sustainable agricultural practices and complies with all relevant national legislation. On its main farmland in Idaho (USA), ALK has implemented several initiatives to support biodiversity, such as:

Diversify 
crops to support 
pollinators
Practice 
crop 
rotations
Minimise 
pesticides and 
fertilisers
Large 
buffer zones for 
biodiversity
Targeted 
lime and no‑till 
practices
Reuse mite 
waste to enrich 
soils

Resource use and circular economy

In 2025 we introduced a global waste policy to reduce environmental impact, promote resource efficiency, and commit to reducing landfill disposal.

75% (1,576 tonnes) of our waste was reused or recycled in 2025, including waste from the production of allergenic source materials.

7% (136 tonnes) operational waste is disposed to landfill.

 

Partnering for sustainability

The challenges of climate change require commitments and partnerships

Last updated: 20.02.2026

CRM-Marketing

Privacy notice for CRM – Marketing

January 2025

According to Article 12 of the General Data Protection Regulation, we must provide you with certain information when we process information about you. This Privacy notice is directed to Health Care Professionals with whom ALK-Abelló A/S communicates in relation to prevention and treatment of allergies, our products and services, seminars, training and events, scientific research and our Company’s activities in general.

ALK-Abelló A/S respects your privacy and is committed to protecting your personal data. This privacy notice will inform you as to how we collect, process, and share your personal data to communicate with you in your capacity as health care professional.

1. Identify and contact details about the data controller

The data controller for the processing described in this notice is:

 

ALK-Abelló A/S

Bøge Allé 6-8

2970 Hørsholm

Denmark

CVR 63717916

 

This signifies that ALK-Abelló A/S determines the objectives for processing your personal data as well as the methods used for such processing. If you have questions regarding this Privacy Notice or our processing of personal data in general, please contact us at data.protection.net.

 

We have appointed a Data Protection Officer which you may contact at:

Bech-Bruun Advokatpartnerselskab

CVR nr.: 3853 8071

Gdanskgade 18

2150 Nordhavn

Denmark

Telephone: + 45 72 27 30 02

E-mail: dpo.alk@bechbruun.com

Secure E-mail Function via: https://dpo.bechbruun.com/alk

2. The Purposes for processing of your personal data

The purposes for collecting this information on you are:

a) to enable us to proactively communicate and provide information to health care professionals which we believe may have an interest in our products and services

b) to enable us to reactively respond to queries and requests from you or other communications on your initiative

c) to target our communication and invitations to seminars, training and events to you to fit what we believe is of most relevance and interest to you

d) to be able to provide public authorities documentation for our communications and activities targeted at health care professionals.

3. The Legal Basis for Processing of your Personal Data

The legal basis for our processing of your personal data for the above purposes is our legitimate interest to provide information to the health care sector of our products and services and generally to increase awareness of allergy and related diseases cf. The General Data Protection Regulation Article 6(1)(f). We have conducted a balancing test to ensure that our interest is not overridden by your interests or fundamental rights and freedoms.

3. 1 Performance of contract

When you register for and participate in seminars, webinars or training events etc. we process your personal data to perform and administer the contract to which you are a party or in order to take steps at your request prior to entering into a contract. The legal basis for our processing of your personal information is the General Data Protection Regulation Article 6(1)(b).

3. 2 Comply with legal obligation

Where we are legally required to keep records of our communication and training and events you have participated in on our invitation, the legal basis for our processing is the General Data Protection Regulation Article 6(1)(c) cf. the Ministerial order on Marketing of Medicines.

We may be legally required to send you pharmacovigilance communication related to products.  The legal basis for our processing of your personal information for such purposes is the General Data Protection Regulation Article 6(1)(c) cf. the Medicines Act.

3.3 E-marketing

We will only send e-mail marketing communications to you if you have provided your specific consent, cf. General Data Protection Regulation 6(1)(a). You may at any time withdraw such consent.

4. Data Sources

Some information we may receive from you when we meet in person at conferences or other events, when you interact with us at our website, or when we communicate with each other.

We may also collect data from publicly available sources such as websites, publications, media coverage, or from third party providers, e.g., reference databases like OneKey.

5. Categories of Personal Data Processed

To communicate with you on subjects which we believe may have your interest we may process the following personal information:

  • name, email, telephone number, postal address
  • organisation that you work for and professional details,
  • educational details, qualifications and publications
  • We will also process information on the communication we have had and seminars, training and other events you have participated in on our invitation.

6. Transfer of Personal Data

i.       ALK EMPLOYEES & EXTERNAL PROCESSORS

The recipients of your personal data will be employees of entities belonging to the ALK Group and external processors providing specific services and processing personal data on our behalf. They will receive your personal data only on a ‘need-to-know’ basis, subject to confidentiality obligations and after signing appropriate legal agreements.

 

ii.       INDEPENDENT THIRD PARTIES

When needed, we may disclose your personal data to independent third parties, such as attorneys, public authorities, or third-party auditors. In other situations, such as when using external shipment or payment providers, you will be involved in the process and, where relevant, offered choices regarding the transaction or payment method.

 

iii.       TRANSFERS OF DATA FROM EU/EEA TO THIRD COUNTRIES

If we share data from the EU/EEA with a company or ALK affiliate in a third country, we will apply contractual clauses that meet EU standards to ensure the receiving company handles personal data appropriately, unless the country where the company operates is already deemed by the EU to offer an adequate level of data protection. More information about such clauses is available here. If data transfers are required in other situations, we will inform you about the specific compliance measures in place to enforce EU law.

 

If you require further information about on our current data processors established outside the EEA and the safety measures in place to allow for the transfer of personal data, you can request it from us – please send your request to us/our Data Protection Officer.

7. Retention Period

Your personal data will be deleted when we no longer have a legitimate purpose to process your data. Generally, this will happen in accordance with the below time frames:

  • When we become aware that you are no longer working as a health care professional
  • If you, on grounds relating to your particular situation, object to our processing based on our legitimate interest, unless we can demonstrate overriding compelling legitimate grounds for continued processing.
  • If we are processing your information on basis of your consent, if you are withdrawing your consent and where there is no other legal ground for the processing.

Data may be retained for a longer period if we are legally obliged to do so, or if retention is necessary to establish, exercise or defend legal claims.

8. Data Subject Rights

The General Data Protection Regulation give you rights in relation to our processing of your personal data.

If you wish to make use of your rights, please contact us by using the information stated in section 1.

a) Right to access

    You can request access to the personal data that we have registered about your, as well as a range of additional information.

b) Right to rectification

    You have the right to have inaccurate personal information about you corrected.

c) Right to erasure

    Above you can read about our retention period. In particular cases, you may have the right to have personal data about you erased before our general deletion deadline occurs.

d) Right to restriction of processing

    In certain cases, you may have the right to restrict the processing of your personal data. If you are entitled to restriction, we may only process the information – apart from storage – with your consent, or for the establishment, exercise, or defence of legal claims, or to protect a person or important public interests.

e) Right to object

    You have the right to object about our processing of your personal data. If you aobject to ALK's processing of your personal data for specific reasons to your particular situation. ALK must not further process the personal data unless ALK demonstrates compelling legitimate grounds for the processing that override your interests, rights and freedoms, or if the processing is necessary for the establishment, exercise, or defence of legal claims.

f) Right to data portability

    In certain cases, you have the right to receive your personal data in a structured, commonly used, and machine-readable format and to have these personal data transferred from one data controller to another without hindrance.

9. Right to Complain

We may for specific purposes ask for your consent to collect and process your personal data. Where our processing is solely based on your specific consent you have the right to with-draw your consent at any time. Such withdrawal will not affect the lawfulness of processing based on consent before its withdrawal.

 

You have the right to lodge a complaint with Datatilsynet, if you are dissatisfied with the way we process your personal data. You can find contact information to Datatilsynet on www.datatilsynet.dk.

Last updated: 04.02.2025

Job application at ALK

Privacy notice related to your job application at ALK

January 2025

As part of our recruitment process through EasyCruit, we are required to provide you with certain information in accordance with Article 13 of the General Data Protection Regulation (GDPR) when we collect personal data about you. Your privacy is important to ALK- Abelló A/S (ALK).

 

In the recruitment process, your personal data will be registered, stored, used, and ultimately deleted. To facilitate the process, we use EasyCruit to collect and store your personal data. EasyCruit ensures that your personal data is securely stored and ultimately deleted.

1. Identify and contact details about the data controller

ALK, as the data controller, is responsible for the processing of your personal data. Therefore, ALK alone sets the purpose and measures for processing your personal data that is collected in connection with your job application at ALK.

 

Our contact information:

ALK-Abelló A/S

Address: Bøge Allé 1

2970 Hørsholm

Denmark

Tel.: 45747576

Email: data.protection@alk.net


 

Data Protection Officer:

Bech-Bruun Advokatpartnerselskab

CVR nr.: 38538071

Gdanskgade 18

2150 Nordhavn

Denmark

Tel.: +45 72 27 30 02

Email: dpo.alk@bechbruun.com

Encrypted email via: https://dpo.bechbruun.com/alk

 

If you have any questions regarding the processing of your personal data, you can always reach

out to ALK or our Data Protection Officer.

2. Purpose for processing

As part of the recruitment process, ALK collects your personal data. The purpose of processing your personal data is to conduct an effective assessment of your skills, qualifications, and suitability for the advertised position. Furthermore, your personal data is processed to communicate with you throughout the recruitment process. Additionally, the purpose of processing your personal data is to facilitate the handling, selection, and initiation of employment applications for the vacant position.

 

The processing of your personal data aims to facilitate an effective recruitment process and to evaluate your suitability for the vacant position.

3. Legal Basis for Processing Personal data

We process your personal data in accordance with applicable data protection laws. Our processing of your personal data is always based on a legal basis.

 

ALK processes your personal data as part of the recruitment process, based on the following legal bases:

  • Article 6(1)(b) of the GDPR, where the processing of your personal data is necessary as part of the recruitment process, upon your request, prior to the potential contract's conclusion.
  • Article 6(1)(f) of the GDPR, where ALK, as a potential employer, may have a legitimate interest in seeking publicly available information about you as a job applicant.

 

We collect and process your personal data to fulfill legal, regulatory, and compliance requirements specific to the country where you have applied.

4. Data Sources

ALK collects personal data that you submit as part of the recruitment process. Personal data includes any information that you provide.

5. Categories of personal data processed

As part of the recruitment process, we process your personal data in our recruitment system, EasyCruit. We process the following personal data about you:

  • Contact information
    • Name
    • Address,
    • Phone number,
    • Email-address
  • Photograph, if you choose to upload it
  • CV and application including:
    • Work experience
    • Qualifications, skills
    • Educational history

6. Transfer of personal data

Generally, your personal data will only be disclosed under limited circumstances. The personal data will be disclosed to the extent necessary for the purpose stated in section 2, to ALK entities globally, including subsidiaries in countries other than your country of residence. These locations may have different data protection laws than your country of residence.

 

Your personal data will be processed by our external provider for our recruitment tool, EasyCruit. EasyCruit acts as a data processor, and a data processing agreement has been entered into to protect your personal data. In addition, your personal data will be disclosed to public authorities and law enforcement agencies as required by applicable law.

 

Your personal data will not be transferred to third countries outside the EU or EEA. We will ensure that any third parties with whom we may share your personal data are required to protect your privacy and comply with applicable data protection laws.

7. Retention period

Your personal data is stored in the cloud service EasyCruit, provided by Recruiting ApS and developed by Visma. ALK will delete your personal data in accordance with the applicable laws and regulations of the specific ALK entity where you have applied for a job. Additionally, your personal data will be retained for approximately six (6) months after the completion of the recruitment process. However, some countries may have longer retention periods.

 

If you are selected and hired for a position you have applied for, your personal data will be stored beyond the mentioned retention period to support the employment process. Furthermore, your CV and application will be retained.

8. Data subject rights

Under the General Data Protection Regulation, you have certain data protection rights:

a) Right to access

    You have the right to request access to your personal data held by ALK, as well as additional details.

b) Right to rectification

    You have the right to request correction of inaccurate or incomplete personal data.

c) Right to erasure

    You have the right to request the deletion of your personal data, except when retention is required by law.

d) Right to restrict processing

    You have the right to request the restriction of your personal data.

e) Right to object

    You have the right to object to the processing of your personal data.

f) Right to data portability

    In specific situations, you are entitled to receive your personal data in a structured, widely used, and machine-readable format.

 

If you would like to exercise any of these rights, please contact us using the contact details provided in section 1.

9. Right to complain

You have the right to file a complaint with the Data Protection Authority if you are dissatisfied with the way we process your personal data. Contact information for the Data Protection Authority can be found on their website.

 

If you have any questions or concerns about this privacy notice or our processing of your personal data, please contact us using the contact details provided in section 1.

Last updated: 04.02.2025

Privacy policy - Newsletter

Privacy notice related to your subscription to our newsletter

January 2025

The purpose of our website is to provide information about our company, products, and services. As part of your visit to our website, ALK (as the data controller) is required to provide you with certain information in accordance with Article 13 of the General Data Protection Regulation (GDPR), such as when you subscribe to our newsletter. Your privacy is important to ALK.

1. Identify and contact details about the data controller

ALK, as the data controller, is responsible for the processing of your personal data. Therefore, ALK solely determines the purposes and measures for processing your personal data collected in connection with your subscription to our newsletter.

 

Our contact information:

ALK-Abelló A/S

Address: Bøge Allé 1

2970 Hørsholm

Denmark

Tel.: 45747576

Email:data.protection@alk.net

 

Data Protection Officer:

Bech-Bruun Advokatpartnerselskab

CVR nr.: 38538071

Gdanskgade 18

2150 Nordhavn

Denmark

Tel.: +45 72 27 30 02

Email: dpo.alk@bechbruun.com

Encrypted email via: https://dpo.bechbruun.com/alk

 

If you have any questions regarding the processing of your personal data, you can always reach out to ALK or our Data Protection Officer.

2. Purpose of processing

We collect information about you to enable you to share information and receive updates.

3. Legal Basis for Processing Personal Data

Our legal basis for processing the personal data listed below is consent.

4. Data Sources

The personal data is obtained directly from you.

5. Categories of Personal Data Processed

Below, you can read about the data we collect from you.

  • Name
  • Email
  • Address
  • Workplace
  • Phone number

6. Transfer of Personal Data

i.       ALK EMPLOYEES & EXTERNAL PROCESSORS

The recipients of your personal data will be employees of entities belonging to the ALK Group and external processors providing specific services and processing personal data on our behalf. They will receive your personal data only on a ‘need-to-know’ basis, subject to confidentiality obligations and after signing appropriate legal agreements.

 

 

ii.       INDEPENDENT THIRD PARTIES

When needed, we may disclose your personal data to independent third parties, such as attorneys, public authorities, or third-party auditors. In other situations, such as when using external shipment or payment providers, you will be involved in the process and, where relevant, offered choices regarding the transaction or payment method.

 

 

iii.       TRANSFERS OF DATA FROM EU/EEA TO THIRD COUNTRIES

If we share data from the EU/EEA with a company or ALK affiliate in a third country, we will apply contractual clauses that meet EU standards to ensure the receiving company handles personal data appropriately, unless the country where the company operates is already deemed by the EU to offer an adequate level of data protection. More information about such clauses is available here. If data transfers are required in other situations, we will inform you about the specific compliance measures in place to enforce EU law.

7. Retention Period

Data will be kept only for as long as you wish or as long as we deem it relevant in the context of the business situation or service, whichever comes first.

8. Data Subject Rights

Under the General Data Protection Regulation (GDPR), you have certain data protection rights:

a) Right to access

    You have the right to request access to your personal data held by ALK, as well as additional details.

b) Right to rectification

    You have the right to request correction of inaccurate or incomplete personal data.

c) Right to erasure

    You have the right to request the deletion of your personal data, except when retention is required by law.

d) Right to restrict processing

    You have the right to request the restriction of your personal data.

e) Right to object

    You have the right to object to the processing of your personal data.

f) Right to data portability

    In specific situations, you are entitled to receive your personal data in a structured, widely used, and machine-readable format.

 

If you would like to exercise any of these rights, please contact us using the contact details provided in section 1.

9. Right to Complain

You have the right to file a complaint with the Data Protection Authority if you are dissatisfied with the way we process your personal data. Contact information for the Data Protection Authority can be found on their website.

If you have any questions or concerns about this privacy notice or our processing of your personal data, please contact us using the contact details provided in section 1.

Last updated: 04.02.2025